Boomerang
[Closed for Investment] Boomerang, with a valuation of $10 million, is raising funds on Title3Funds. It is a digital health company focused on at-home diagnostic testing, customizable wellness plans, and strategic partnerships. The at-home test kits of Boomerang are convenient and accurate and span across tests, including diabetes, food sensitivity, food allergy, STDs, UTI, and COVID-19. Boomerang has a loyal customer base and expects to reach $25 million in revenue by 2023. Frank Gianotti founded Boomerang in October 2022. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5 million. The campaign proceeds will be used for marketing, equipment purchases, accounting fees, and general working capital.
Investment Overview
Raised: $2,000
Deal Terms
Total Commitments ($USD)
- Platform
- Title3Funds
- Start Date
- 01/13/2023
- Close Date
- 06/23/2023
$10,000
$5,000,000
$250
Equity - Common
Pre-Seed
RegCF
$1.00
$10,000,000
Company & Team
Company
- Year Founded
- 2022
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- Medium
- Capital Intensity
- Low
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $0
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 06/23/2023 | Title3Funds | $10,000,000 | $2,000 | Equity - Common | Not Funded | RegCF |